Molecular structure pattern

Pityriasis (Tinea) Versicolor Disease Summary

Last updated: 28 April 2026

Overview

Pityriasis versicolor is a common, benign, superficial fungal infection localized to the stratum corneum, as stated in the Introduction section.   

Tinea versicolor occurs worldwide but is more common in summer than winter months. A detailed discussion about the prevalence of pityriasis versicolor is in the Epidemiology section.

Pityriasis versicolor is caused by a lipophilic yeast, Malassezia spp, as stated in the Etiology section.

The Pathophysiology section states that the transformation of Malassezia from its normal yeast form into a pathogenic, filamentous (mycelial) form is the key event that triggers tinea versicolor. The developmental process of pityriasis versicolor is in this section.
 
The Risk Factors section enumerates the conditions that promote pityriasis versicolor infection.



Pityriasis Versicolor_Disease SummaryPityriasis Versicolor_Disease Summary

History and Physical Examination

The Clinical Presentation section describes the clinical features suggestive of tinea versicolor in affected persons.

The History section and the Physical Examination section emphasize the importance of a careful history and evaluation in patients suspected of tinea versicolor.

Diagnosis

Discussions on microscopy, culture, and Wood’s light exam in the diagnosis of pityriasis versicolor are in the Laboratory Tests and Ancillaries section.  

Other conditions with similar appearance to tinea versicolor are listed in the Differential Diagnosis section.

Management

General therapy principles and management of pityriasis versicolor are in the Principles of Therapy section.

The Pharmacological Therapy section discusses treatment options such as topical and oral antifungals, Selenium sulfide and imidazoles used in the management of pityriasis versicolor.

The Nonpharmacological section includes things to educate the patient about the management of pityriasis versicolor.  

The Monitoring section enumerates several indications for considering a dermatology referral in patients with tinea versicolor.